FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2139313603> ?p ?o ?g. }

• W2139313603 endingPage "80" @default.
• W2139313603 startingPage "5475" @default.
• W2139313603 abstract "Acute chemotherapy-associated exacerbation of interstitial lung disease (ILD) can occur in patients with non-small cell lung cancer (NSCLC). The safety and efficacy of cytotoxic chemotherapy has not yet been established for NSCLC with ILD. Thus, patients with advanced NSCLC with ILD usually receive only best supportive care. The aim of this study was to assess the safety and efficacy profiles of the combination chemotherapy of vinorelbine and a platinum agent in patients with advanced NSCLC with ILD.Nineteen patients with advanced NSCLC with ILD treated with vinorelbine and a platinum agent, either cisplatin or carboplatin, were retrospectively reviewed to examine acute exacerbation of ILD, toxicity, response rate, and survival time. Additionally, possible predictive factors for acute chemotherapy-associated exacerbation of ILD were analyzed.The response rate was 42.1%, the progression-free survival time was 4.4 months, the median survival time was 7.4 months, and the one-year survival rate was 36.8%. Neutropenia was the most frequent grade 3 to 4 toxicity and it occurred in 63.2% of patients. Acute chemotherapy-associated exacerbation of ILD occurred in three patients (15.8%) and caused the death of one of these patients (5.3%). No variables were identified as being predictive factors for acute chemotherapy-associated exacerbation of ILD.The combination chemotherapy with vinorelbine and a platinum agent can be considered as a treatment option for patients with advanced NSCLC with ILD, with careful management after sufficient evaluation of the risks and the benefits." @default.
• W2139313603 created "2016-06-24" @default.
• W2139313603 creator A5000850367 @default.
• W2139313603 creator A5009618044 @default.
• W2139313603 creator A5016135291 @default.
• W2139313603 creator A5027549438 @default.
• W2139313603 creator A5030270959 @default.
• W2139313603 creator A5033641107 @default.
• W2139313603 creator A5042017809 @default.
• W2139313603 creator A5058813774 @default.
• W2139313603 creator A5062052264 @default.
• W2139313603 creator A5073485705 @default.
• W2139313603 creator A5077367961 @default.
• W2139313603 creator A5082628144 @default.
• W2139313603 date "2012-12-01" @default.
• W2139313603 modified "2023-09-26" @default.
• W2139313603 title "Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease." @default.
• W2139313603 cites W1770545381 @default.
• W2139313603 cites W1913616561 @default.
• W2139313603 cites W1965974903 @default.
• W2139313603 cites W1970902896 @default.
• W2139313603 cites W1983799927 @default.
• W2139313603 cites W1993946952 @default.
• W2139313603 cites W1995105009 @default.
• W2139313603 cites W2021483622 @default.
• W2139313603 cites W2039472941 @default.
• W2139313603 cites W2050238275 @default.
• W2139313603 cites W2057093079 @default.
• W2139313603 cites W2085336270 @default.
• W2139313603 cites W2094116236 @default.
• W2139313603 cites W2099725888 @default.
• W2139313603 cites W2119366998 @default.
• W2139313603 cites W2123982639 @default.
• W2139313603 cites W2130955829 @default.
• W2139313603 cites W2134764017 @default.
• W2139313603 cites W2137748315 @default.
• W2139313603 cites W2139248078 @default.
• W2139313603 cites W2140724906 @default.
• W2139313603 cites W2142628255 @default.
• W2139313603 cites W2145835533 @default.
• W2139313603 cites W2151090489 @default.
• W2139313603 cites W2161955176 @default.
• W2139313603 cites W2163779649 @default.
• W2139313603 cites W2169164143 @default.
• W2139313603 cites W2325303226 @default.
• W2139313603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23225454" @default.
• W2139313603 hasPublicationYear "2012" @default.
• W2139313603 type Work @default.
• W2139313603 sameAs 2139313603 @default.
• W2139313603 citedByCount "15" @default.
• W2139313603 countsByYear W21393136032013 @default.
• W2139313603 countsByYear W21393136032015 @default.
• W2139313603 countsByYear W21393136032017 @default.
• W2139313603 countsByYear W21393136032018 @default.
• W2139313603 countsByYear W21393136032020 @default.
• W2139313603 countsByYear W21393136032021 @default.
• W2139313603 countsByYear W21393136032022 @default.
• W2139313603 countsByYear W21393136032023 @default.
• W2139313603 crossrefType "journal-article" @default.
• W2139313603 hasAuthorship W2139313603A5000850367 @default.
• W2139313603 hasAuthorship W2139313603A5009618044 @default.
• W2139313603 hasAuthorship W2139313603A5016135291 @default.
• W2139313603 hasAuthorship W2139313603A5027549438 @default.
• W2139313603 hasAuthorship W2139313603A5030270959 @default.
• W2139313603 hasAuthorship W2139313603A5033641107 @default.
• W2139313603 hasAuthorship W2139313603A5042017809 @default.
• W2139313603 hasAuthorship W2139313603A5058813774 @default.
• W2139313603 hasAuthorship W2139313603A5062052264 @default.
• W2139313603 hasAuthorship W2139313603A5073485705 @default.
• W2139313603 hasAuthorship W2139313603A5077367961 @default.
• W2139313603 hasAuthorship W2139313603A5082628144 @default.
• W2139313603 hasConcept C126322002 @default.
• W2139313603 hasConcept C143998085 @default.
• W2139313603 hasConcept C2776256026 @default.
• W2139313603 hasConcept C2776694085 @default.
• W2139313603 hasConcept C2777014857 @default.
• W2139313603 hasConcept C2777063308 @default.
• W2139313603 hasConcept C2777543607 @default.
• W2139313603 hasConcept C2777714996 @default.
• W2139313603 hasConcept C2778239845 @default.
• W2139313603 hasConcept C2778850193 @default.
• W2139313603 hasConcept C2780350996 @default.
• W2139313603 hasConcept C2781451048 @default.
• W2139313603 hasConcept C71924100 @default.
• W2139313603 hasConceptScore W2139313603C126322002 @default.
• W2139313603 hasConceptScore W2139313603C143998085 @default.
• W2139313603 hasConceptScore W2139313603C2776256026 @default.
• W2139313603 hasConceptScore W2139313603C2776694085 @default.
• W2139313603 hasConceptScore W2139313603C2777014857 @default.
• W2139313603 hasConceptScore W2139313603C2777063308 @default.
• W2139313603 hasConceptScore W2139313603C2777543607 @default.
• W2139313603 hasConceptScore W2139313603C2777714996 @default.
• W2139313603 hasConceptScore W2139313603C2778239845 @default.
• W2139313603 hasConceptScore W2139313603C2778850193 @default.
• W2139313603 hasConceptScore W2139313603C2780350996 @default.
• W2139313603 hasConceptScore W2139313603C2781451048 @default.
• W2139313603 hasConceptScore W2139313603C71924100 @default.
• W2139313603 hasIssue "12" @default.

• next